PMID:10843852

Citation	Fresquet, V, Mora, P, Rochera, L, Ramón-Maiques, S, Rubio, V and Cervera, J (2000) Site-directed mutagenesis of the regulatory domain of Escherichia coli carbamoyl phosphate synthetase identifies crucial residues for allosteric regulation and for transduction of the regulatory signals. J. Mol. Biol. 299:979-91
Abstract	Carbamoyl phosphate (CP), the essential precursor of pyrimidines and arginine, is made in Escherichia coli by a single carbamoyl phosphate synthetase (CPS) consisting of 41.4 and 117.7 kDa subunits, which is feed-back inhibited by UMP and activated by IMP and ornithine. The large subunit catalyzes CP synthesis from ammonia in three steps, and binds the effectors in its 15 kDa C-terminal domain. Fifteen site-directed mutations were introduced in 13 residues of this domain to investigate the mechanism of allosteric modulation by UMP and IMP. Two mutations, K993A and V994A, decreased significantly or abolished enzyme activity, apparently by interfering with the step of carbamate synthesis, and one mutation, T974A, negatively affected ornithine activation. S948A, K954A, T974A, K993A and K993W/H995A abolished or greatly hampered IMP activation and UMP inhibition as well as the binding of both effectors, monitored using photoaffinity labeling and ultracentrifugation binding assays. V994A also decreased significantly IMP and UMP binding. L990A, V991A, H995A, G997A and G1008A had more modest effects or affected more the modulation by and the binding of one than of the other nucleotide. K993W, R1020A, R1021A and K1061A were without substantial effects. The results confirm the independence of the regulatory and catalytic centers, and also confirm functional predictions based on the X-ray structure of an IMP-CPS complex. They prove that the inhibitor UMP and the activator IMP bind in the same site, and exclude that the previously observed binding of ornithine and glutamine in this site were relevant for enzyme activation. K993 and V994 appear to be involved in the transmission of the regulatory signals triggered by UMP and IMP binding. These effectors possibly change the position of K993 and V994, and alter the intermolecular contacts mediated by the regulatory domain.
Links	PubMed Online version:10.1006/jmbi.2000.3794
Keywords	Allosteric Regulation/drug effects; Allosteric Site/drug effects; Amino Acid Substitution/genetics; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)/antagonists & inhibitors; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)/chemistry; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)/genetics; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)/metabolism; Catalysis/drug effects; Enzyme Activation/drug effects; Escherichia coli/enzymology; Escherichia coli/genetics; Escherichia coli/growth & development; Genetic Complementation Test; Inosine Monophosphate/metabolism; Inosine Monophosphate/pharmacology; Kinetics; Models, Molecular; Mutagenesis, Site-Directed/genetics; Mutation/genetics; Ornithine/metabolism; Ornithine/pharmacology; Photoaffinity Labels/metabolism; Protein Binding; Protein Conformation; Protein Structure, Tertiary/drug effects; Thermodynamics; Ultracentrifugation; Uridine Monophosphate/metabolism; Uridine Monophosphate/pharmacology
edit table

Annotations

Gene product	Qualifier	GO ID	GO term name	Evidence Code	with/from	Aspect	Notes	Status
edit table

References

See Help:References for how to manage references in GONUTS.